This brand name is authorized in France, Israel, Lithuania, Tunisia
The drug PERMIXON contains one active pharmaceutical ingredient (API):
|
1
Serenoa repens extract
UNII 487DXM62F2 - SERENOA REPENS WHOLE
|
|
|
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| G04CX02 | Sabalis serrulatae fructus | G Genito urinary system and sex hormones → G04 Urologicals → G04C Drugs used in benign prostatic hypertrophy → G04CX Other drugs used in benign prostatic hypertrophy |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: FR | Base de données publique des médicaments | Identifier(s): 60074432, 60079721, 60200678, 60263461, 60953665, 61679256, 61743292, 62695740, 63398507, 64472177, 65788274, 66515809, 68830999 |
| Country: IL | מִשְׂרַד הַבְּרִיאוּת | Identifier(s): 4590 |
| Country: LT | Valstybinė vaistų kontrolės tarnyba | Identifier(s): 1016065 |
| Country: TN | Direction de la Pharmacie et du Médicament | Identifier(s): 6063022 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
